Settlement with Karin Bergqvist

Settlement with Karin Bergqvist

RLS Global AB has reached a settlement with Dr. Karin Bergqvist, who is one of the two inventors of ChloraSolv. Dr. Bergqvist had taken legal action against RLS Global AB, claiming additional compensation for her earlier assignment of her rights to the invention of ChloraSolv. The outcome of the settlement was significantly less than the original claim in the lawsuit and does not include any immediate payment to Dr. Karin Bergqvist. The compensation model is based on a small percentage of the net sales. The settlement will have an insignificant impact on the result developmed by RLS Global AB the next couple of years.

We can now concentrate all our resources on commercializing ChloraSolv into the market for diabetic foot ulcers in accordance with our newly issued CE certificate, says Karin Fischer.

For more information, please contact:

Karin Fischer, CEO RLS Global AB

+46 (0)702 48 46 51, karin.fischer@rlsglobal.se

Eva Jagenheim, CFO RLS Global AB

+46 (0)76 133 27 47, eva.jagenheim@rlsglobal.se

PUBLICATION

This information is information that RLS Global AB (public) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at June 19, 2019, at 12.00

About RLS Global
For more than 20 years, RLS Global has worked with Oral Care specialists, pioneering new therapies for Oral Care and their patients. We are now taken another major step toward easier and more effective care within Wound Care. We will continue to work with Health care Professionals to ensure to develop a treatment that further helps deliver the best care for each patient. The method is clinically proven and saves the patient a lot of suffering. Our focus is on caring for the patients, developing efficient and safe products that offer gentle treatment methods. We’re proud to provide Minimally Invasive Therapy which provides Quality of Life for patients worldwide.